Skip to main content

Table 2 Concordance rate between IHC and BDISH techniques for evaluating Her2/neu protein/gene status in transitional cell carcinoma of urinary bladder (p < 0.005)

From: Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques

 

Her2/neu gene status (BDISH)

Non-Amplified (≤2)

Amplified (>2)

Total

Her2/neu protein expression patterns (IHC)

Weak Expression (0,1+)

60 (100 %)

0 (0 %)

60

Borderline/equivocal Expression (2+)

46 (79 %)

12 (21 %)

58

High Expression (3+)

11 (29 %)

27 (71 %)

38

Total

117

39

156